Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vital Farms (VITL) Capital Expenditures (2019 - 2025)

Vital Farms' Capital Expenditures history spans 7 years, with the latest figure at -$34.8 million for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 223.23% year-over-year to -$34.8 million; the TTM value through Dec 2025 reached $9.3 million, down 67.69%, while the annual FY2025 figure was $9.3 million, 67.69% down from the prior year.
  • Capital Expenditures for Q4 2025 was -$34.8 million at Vital Farms, down from $34.0 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $34.0 million in Q3 2025 and bottomed at -$34.8 million in Q4 2025.
  • The 5-year median for Capital Expenditures is $1.3 million (2022), against an average of $2.0 million.
  • The largest annual shift saw Capital Expenditures crashed 455.52% in 2021 before it skyrocketed 11924.73% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at -$12.7 million in 2021, then surged by 54.68% to -$5.8 million in 2022, then crashed by 55.53% to -$9.0 million in 2023, then soared by 415.19% to $28.2 million in 2024, then crashed by 223.23% to -$34.8 million in 2025.
  • Per Business Quant, the three most recent readings for VITL's Capital Expenditures are -$34.8 million (Q4 2025), $34.0 million (Q3 2025), and $9.5 million (Q2 2025).